EG18379A - Novel pharmacological compounds - Google Patents

Novel pharmacological compounds

Info

Publication number
EG18379A
EG18379A EG669/87A EG66987A EG18379A EG 18379 A EG18379 A EG 18379A EG 669/87 A EG669/87 A EG 669/87A EG 66987 A EG66987 A EG 66987A EG 18379 A EG18379 A EG 18379A
Authority
EG
Egypt
Prior art keywords
pharmacological compounds
novel pharmacological
compounds
novel
formulapharmaceutical
Prior art date
Application number
EG669/87A
Other languages
English (en)
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604998A external-priority patent/SE8604998D0/xx
Priority claimed from SE8605551A external-priority patent/SE8605551D0/xx
Priority claimed from SE8704049A external-priority patent/SE8704049D0/xx
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of EG18379A publication Critical patent/EG18379A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG669/87A 1986-11-21 1987-11-19 Novel pharmacological compounds EG18379A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8604998A SE8604998D0 (sv) 1986-11-21 1986-11-21 Novel pharmacological compounds
SE8605551A SE8605551D0 (sv) 1986-12-23 1986-12-23 Novel pharmacological compounds
SE8704049A SE8704049D0 (sv) 1987-10-16 1987-10-16 Novel pharmacological compounds

Publications (1)

Publication Number Publication Date
EG18379A true EG18379A (en) 1992-11-30

Family

ID=27355365

Family Applications (1)

Application Number Title Priority Date Filing Date
EG669/87A EG18379A (en) 1986-11-21 1987-11-19 Novel pharmacological compounds

Country Status (24)

Country Link
EP (3) EP0510719A1 (fr)
JP (1) JPH02500744A (fr)
KR (1) KR890700125A (fr)
AT (1) ATE84032T1 (fr)
AU (1) AU612129B2 (fr)
DE (1) DE3783356T2 (fr)
DK (1) DK365488A (fr)
EG (1) EG18379A (fr)
ES (1) ES2052603T3 (fr)
FI (1) FI892454A (fr)
GR (1) GR3007385T3 (fr)
HU (1) HU204814B (fr)
IE (2) IE61178B1 (fr)
IL (1) IL84504A (fr)
IS (1) IS1565B (fr)
LV (1) LV10954B (fr)
MY (1) MY101784A (fr)
NO (1) NO173998C (fr)
NZ (2) NZ234564A (fr)
PL (1) PL157655B1 (fr)
PT (1) PT86186B (fr)
RU (1) RU2062778C1 (fr)
WO (1) WO1988003921A1 (fr)
YU (1) YU47116B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
WO1990003373A1 (fr) * 1988-09-20 1990-04-05 Hisamitsu Pharmaceutical Co., Inc. NOUVEAUX DERIVES DE DIBENZ[b,e]OXEPINE
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
CA2083606C (fr) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Derives de dialcoxypyridinylbenzimidazole; methode de preparation et utilisation en pharmacie
DE69132082T2 (de) * 1990-10-17 2000-08-31 Takeda Chemical Industries Ltd Pyridin-Derivate, Verfahren zu deren Herstellung und Anwendung
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
JP2759228B2 (ja) * 1992-05-21 1998-05-28 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
WO1994026279A1 (fr) * 1993-05-18 1994-11-24 The Upjohn Company Esters de biphosphonate pour traiter les troubles gastriques
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
EP0983263A1 (fr) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
WO1999033846A2 (fr) * 1997-12-31 1999-07-08 The University Of Kansas Remedes contenant des precurseurs hydrosolubles d'amines secondaires et tertiaires, et leurs procedes d'obtention
WO2001044257A1 (fr) * 1999-12-17 2001-06-21 Ariad Pharmaceuticals, Inc. Inhibiteurs de la pompe a protons
AU2001294228A1 (en) * 2000-10-12 2002-04-22 Takeda Chemical Industries Ltd. Benzimidazole compounds, process for producing the same and use thereof
EP1437352A4 (fr) * 2001-09-25 2004-12-08 Takeda Chemical Industries Ltd Compose de benzymidazole, procede de production et d'utilisation de celui-ci
WO2007014846A1 (fr) * 2005-07-28 2007-02-08 Intervet International B.V. Nouveaux benzimidazolyl(thio)carbamates ayant une activité antiparasitaire et synthèse de ceux-ci
CA3000985C (fr) 2014-10-14 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Procede pour le traitement de maladies neurodegeneratives
RS61053B1 (sr) 2015-12-15 2020-12-31 Univ Leland Stanford Junior Pоstupak za sprečavanje i / ili lečenje kognitivnog oštećenja povezanog sa starenjem i neuroinflamacijom
BR112021002165A2 (pt) 2018-08-06 2021-05-04 The Board Of Trustees Of The Leland Stanford Junior University composto, composição farmacêutica, e, métodos para tratar uma doença neurodegenerativa e deficiência cognitiva associada ao envelhecimento e neuroinflamação
EP4019496B1 (fr) * 2019-08-20 2024-06-05 ONO Pharmaceutical Co., Ltd. Sel et forme cristalline d'un composé ayant une activité agoniste vis-à-vis du récepteur s1p5

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fr) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS5836312B2 (ja) * 1978-08-21 1983-08-08 日本電信電話株式会社 通信用平衡ケ−ブル線路の障害位置測定方式
JPS5687818A (en) * 1979-12-19 1981-07-16 Ishikawajima Harima Heavy Ind Co Ltd Reflex type position detector
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
JPS57137860A (en) * 1981-02-20 1982-08-25 Sumitomo Electric Ind Ltd Optical tachometer
JPS5999597A (ja) * 1982-11-30 1984-06-08 株式会社東芝 光学測定装置
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6020051U (ja) * 1983-07-19 1985-02-12 三洋電機株式会社 カセツト収納装置
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds

Also Published As

Publication number Publication date
JPH02500744A (ja) 1990-03-15
PT86186B (pt) 1990-08-31
NZ234564A (en) 1991-04-26
FI892454A0 (fi) 1989-05-19
LV10954A (lv) 1995-12-20
PT86186A (en) 1987-12-01
EP0510719A1 (fr) 1992-10-28
HUT51269A (en) 1990-04-28
IE940326L (en) 1988-05-21
ES2052603T3 (es) 1994-07-16
NO173998C (no) 1994-03-02
EP0332647A1 (fr) 1989-09-20
NO883229D0 (no) 1988-07-20
LV10954B (en) 1996-08-20
WO1988003921A1 (fr) 1988-06-02
DK365488D0 (da) 1988-07-01
MY101784A (en) 1992-01-17
IS3284A7 (is) 1988-05-22
AU612129B2 (en) 1991-07-04
IL84504A (en) 1994-10-07
DE3783356D1 (de) 1993-02-11
GR3007385T3 (fr) 1993-07-30
PL157655B1 (pl) 1992-06-30
NO173998B (no) 1993-11-22
DK365488A (da) 1988-07-01
KR890700125A (ko) 1989-03-02
IE61178B1 (en) 1994-10-05
YU211087A (en) 1988-12-31
YU47116B (sh) 1994-12-28
RU2062778C1 (ru) 1996-06-27
EP0279149B1 (fr) 1992-12-30
IE873125L (en) 1988-05-21
NZ222495A (en) 1991-04-26
IS1565B (is) 1994-12-13
HU204814B (en) 1992-02-28
AU8330287A (en) 1988-06-16
EP0279149A3 (en) 1988-08-31
ATE84032T1 (de) 1993-01-15
PL268927A1 (en) 1989-01-23
EP0279149A2 (fr) 1988-08-24
DE3783356T2 (de) 1993-04-15
FI892454A (fi) 1989-05-19
NO883229L (no) 1988-09-16

Similar Documents

Publication Publication Date Title
EG18379A (en) Novel pharmacological compounds
JO1502B1 (en) New pharmacy vehicles
IL82448A0 (en) Tetrahydronaphthalene derivatives,their manufacture and pharmaceutical compositions containing them
IL84315A0 (en) Hydrogenated phenylbenzopyrans,their preparation and pharmaceutical compositions containing them
HK75594A (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
SE8404065D0 (sv) Novel biologically active compounds
JO1406B1 (en) Chemical compounds
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
HUT46929A (en) Sposob poluchenija aminoglycoside-steroides and pharmaceutical compositions containing them as active components
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
JO1531B1 (en) New near-compounds
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
EG18336A (en) Insectidal composition comprising more than one active ingredients
IL82984A0 (en) N-(imidazolylmethyl)diphenylazomethines,their preparation and compositions containing them
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
DE3573724D1 (en) Use of 1,8,9-triacetoxy-anthracene as the active ingredient in the preparation of an antitumoral pharmaceutical compound
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments